Bulletin
Investor Alert

New York Markets After Hours

Topics

Flu

Video

WSJ Opinion: Was Pausing Johnson & Johnson's Covid Vaccine a Good Idea?

  • WSJ Opinion: Was Pausing Johnson & Johnson's Covid Vaccine a Good Idea? WSJ Opinion: Was Pausing Johnson & Johnson's Covid Vaccine a Good Idea? 6:04
    WSJ Opinion: The Making of an Asian-American Hate Narrative WSJ Opinion: The Making of an Asian-American Hate Narrative 4:25
    WSJ Opinion: Joe Biden's Super State WSJ Opinion: Joe Biden's Super State 5:42
    The Science Behind How the Coronavirus Affects the Brain The Science Behind How the Coronavirus Affects the Brain 7:20
9:28 p.m. April 18, 2021 - By Quentin Fottrell
The public’s expectation of perfection: Risk of blood clot from Johnson & Johnson COVID-19 vaccine is 0.00009% ‘It’s the same perceptual problem when we blindly drive to the airport texting, yet worry about the airplane’‘It’s the same perceptual problem when we blindly drive to the airport texting, yet worry about the airplane.’
5:58 a.m. April 11, 2021 - By Quentin Fottrell
Weary of #fakenews, more Americans are getting their COVID-related news from peer-reviewed medical journals Social media doesn’t help people differentiate what is real from what is fake, but this class of publications mightSocial media doesn’t help people differentiate what is real from what is fake, but this class of publications might.
9:35 a.m. April 5, 2021 - By Tomi Kilgore
Chembio Diagnostics stock rockets on record volume after commercial launch of rapid COVID-19 testShares of Chembio Diagnostics Inc. skyrocketed 63.8% on record volume in afternoon trading Monday, to pace all gainers listed on major U.S. exchanges, in the wake of the point-of-care diagnostics company's announcement of the commercial launch of its rapid COVID-19/flu test. The stock was on track for the biggest one-day percentage gain since it doubled, on March 12, 2004. Trading volume ballooned to 206.6 million shares, compared with the full-day average of less than 1 million shares. The company said its test has been granted emergency use authorization by the Food and Drug Administration. Chembio said after Thursday's closing bell that the product, which produces results in 15 minutes, requires no instrumentation and simultaneously differentiates SARS-CoV-2 antigens and influenza Type A and Type B infections, is immediately available for shipment. "As COVID-19 converges with the flu, it is critical for physicians to be able to quickly differentiate between these viruses at the point-of-care, which present with nearly identical symptoms, in order to take appropriate clinical actions and maximize efficient use of healthcare resources," said Charles Caso, vice president of sales and marketing at Chembio. The stock has run up 21.4% year to date, while the S&P 500 has gained 8.6%.
1:38 p.m. April 3, 2021 - By MarketWatch
These money and investing tips can put a spring in your investing stepsMoney and investing stories popular with MarketWatch readers over the past week.
5:34 a.m. April 3, 2021 - By Quentin Fottrell
‘Frugality will continue to reign’: Eager to save hundreds of dollars, Americans flock to one type of product A new report from the Conference Board tracks three distinct trendsA new report from the Conference Board tracks three distinct trends.
3:24 a.m. March 30, 2021 - By Jaimy Lee
BD gets FDA authorization for test that can detect COVID-19 and the fluBecton, Dickinson & Co. said it received emergency authorization from the Food and Drug Administration for a rapid, antigen test that can detect SARS-CoV-2 and two types of influenza. The test, which runs on the company's BD Veritor System, takes about 15 minutes to produce results and is expected to be available this summer. BD's stock has gained 10.9% over the past 12 months, while the broader S&P 500 is up 56.2%.
1:23 p.m. March 25, 2021 - By Andrew Keshner
Real-estate agents are rethinking decades of advice on pools and how COVID-19 rewrote American shopping lists Thursday’s Personal Finance Stories Thursday’s Personal Finance StoriesThursday’s Personal Finance Stories.
12:19 p.m. March 24, 2021 - By Claudia Assis
Rite Aid stock down 18% after lower 2021 guidance on 'soft' flu seasonShares of Rite Aid Corp. fell more than 18% in the extended session Wednesday after the drugstore chain lowered its guidance for fiscal 2021, saying its bottom line was "significantly" hampered by a "soft" cold and flu season, the ongoing pandemic, and "challenging" weather. Same-store sales fell about 5.6% in the quarter ended in February, mostly due to a decline of nearly 37% percent in cough, cold and flu-related categories, the company said. Rite Aid also said it had administered about 1 million COVID-19 vaccines in March to date. The company said it expects fiscal 2021 revenue of about $24 billion, with same-store sales expected to increase about 3.5% compared with fiscal 2020. It called for a net loss between $90 million and $100 million for the year, and an adjusted EBITDA between $425 million and $435 million. Liquidity is about $1.7 billion, it said. Rite Aid is scheduled to report fourth-quarter results on April 15. The stock ended the regular trading day down 2.4%.
5:01 a.m. March 10, 2021 - By Tonya Garcia
CVS locations in Target stores will begin administering COVID-19 vaccinationsTarget Corp. announced Wednesday that with CVS Health Corp. locations will administer COVID-19 vaccinations. Target and CVS have already partnered for flu, shingles and pneumonia vaccinations. The retailer will also make fitting rooms available for appointments. Target provides in order for employees to be vaccinated. Target stock has gained 65.4% over the past year while the S&P 500 index is up 34.5% for the period.
7:16 a.m. March 1, 2021 - By Alicia H. Munnell
Has COVID-19 really affected life expectancy? Many died in 2020-2021, but hopefully it is a one-shot event Many died in 2020-2021, but hopefully it is a one-shot event
4:10 a.m. Feb. 17, 2021 - By Jaimy Lee
Vir, GSK ink new R&D deal Shares of Vir Biotechnology Inc. were up 12.8% in premarket trading on Wednesday after the company said it would expand its research agreement with GlaxoSmithKline to include the flu and other respiratory diseases. As part of the deal, GSK will pay Vir $225 million upfront and will make an equity investment of $120 million in the biotech; it also has the option to develop one drug for $300 million, with the possibility of an additional $200 million in milestone payments. The companies had initially engaged in a deal in 2020 that is focused on studying treatments for coronaviruses, including SARS-CoV-2. One experimental COVID-19 treatment that the companies are already developing is VIR-7831, which is being tested in Phase 3 studies as a monotherapy and in a mid-stage trial as a combination therapy. Vir's stock has soared 287.7% over the past 12 months, while the broader S&P 500 is up 16.%.
9:00 a.m. Feb. 1, 2021 - By Jaimy Lee
U.S. to pay testing company $231 million to speed up production of at-home COVID-19 testsThe Department of Defense awarded $231 million to Ellume, a privately held Australian diagnostic testing company that for its at-home COVID-19 test. The funding is expected to help increase the number of tests that the company can manufacture in the U.S., with a goal of producing 640,000 tests per day by the end of this year. As part of the agreement, the U.S. government also plans to purchase 8.5 million tests from Ellume. The test can be bought over-the-counter, similar to some cold-and-flu and allergy medicines. It costs $30.
7:26 a.m. Jan. 27, 2021 - By Quentin Fottrell
CDC Director: ‘I can’t tell you how much vaccine we have and, if I can’t tell it to you, then I can’t tell it to the governors’ President Joe Biden has outlined a goal of 100 million vaccinations in 100 days, which some analysts describe as ambitiousPresident Joe Biden has outlined a goal of 100 million vaccinations in 100 days, which some analysts describe as ambitious.
8:16 a.m. Jan. 24, 2021 - By Quentin Fottrell
Why do I need to wear a mask if I’ve had COVID-19? Who is it protecting? Can I really be reinfected? ‘Like everyone else, I am hoping that the vaccine will help infection rates and more people can get back to work’‘Like everyone else, I am hoping that the vaccine will help infection rates, and more people can get back to work.’
5:39 a.m. Jan. 17, 2021 - By Quentin Fottrell
Biden’s $1.9-trillion COVID-19 rescue plan is a ‘lifeline’ for millions of Americans President-elect Joe Biden said he will call for $1,400 stimulus checks and more vaccine funds in a new coronavirus economic relief package when he takes office this monthPresident-elect Biden said he will call for $1,400 stimulus checks and more vaccine funds in a new coronavirus economic relief package when he takes office this month.
5:16 a.m. Jan. 16, 2021 - By Quentin Fottrell
I didn’t receive a $1,200 stimulus check during the first surge of COVID-19. Will I get a payment this time around? President-elect Bidens said Thursday he will call for $1,400 stimulus checks and more vaccine funds in $1.9-trillion COVID-19 relief plan. President-elect Bidens said Thursday he will call for $1,400 stimulus checks and more vaccine funds in $1.9-trillion COVID-19 relief plan.
11:02 a.m. Jan. 15, 2021 - By Ciara Linnane
Global deaths from COVID-19 top 2 million as U.S. suffers most weekly fatalities since start of the pandemic Weekly deaths exceed CDC’s estimate for flu-related deaths for entire 2019-2020 season The global case tally for the coronavirus-borne illness COVID-19 climbed above 93 million on Friday and the death toll climbed above 2 million, with the U.S. leading all nations by cases and fatalities.
10:21 a.m. Jan. 13, 2021 - By Ciara Linnane
U.S. sees record one-day death toll and experts worry new variant may make activities like plane travel more risky Vaccine program must speed up to avoid reaching 640,000 deaths by spring, equal to lives lost in the 1918 flu pandemicThe U.S. set another grim milestone in the coronavirus pandemic on Tuesday, when more than 4,400 COVID-19 patients died, the most in a single day since the start of the outbreak, and experts said that with cases continuing to accelerate, the worst is still to come.
3:42 a.m. Jan. 11, 2021 - By Jaimy Lee
Moderna to develop vaccine candidates for seasonal flu, HIVShares of Moderna Inc. were up 1.3% in premarket trading on Monday after the company said it plans to launch new development programs using its mRNA technology that will focus on developing vaccines for seasonal flu, HIV, and the Nipah virus. This follows the success of its mRNA COVID-19 vaccine, which is one of two vaccines to be authorized so far in the U.S. CEO Moderna also said it plans to expand its respiratory syncytial virus to include older adults, and it plans to test different vaccine combinations that fight the flu, COVID-19, RSV, and human metapneumovirus. "The uniquely challenging year of 2020 for all of society proved to be an extraordinary proof-of-concept period for Moderna," CEO Stéphane Bancel said in a news release. As part of its corporate update, Moderna said it had about $5.2 billion in cash as of Dec. 31, compared to the $1.2 billion in cash it had at the same time a year ago, and it expects to generate at least $11.7 billion in revenue in 2021 for its COVID-19 vaccine based on advance purchase agreements. Moderna's stock has soared 489.1% over the last year, while the S&P 500 is up 19.7%.
1:54 p.m. Jan. 10, 2021 - By Andrew Keshner
What side effects, if any, can you expect from a COVID-19 vaccine shot? Doctors have advised the CDC to be transparent and forthcoming about any side effectsDoctors have advised the CDC to be transparent and forthcoming about any side effects.
11:18 a.m. Dec. 7, 2020 - By Quentin Fottrell
Biden wants Americans to wear masks for 100 days — do they protect against COVID-19 or merely promote healthy behavior? ‘Modeling suggests that near universal masking could prevent 180,000 COVID-19 deaths,’ one expert told MarketWatch‘Modeling suggests that near universal masking could prevent 180,000 COVID-19 deaths,’ one expert told MarketWatch.
7:46 a.m. Dec. 7, 2020 - By Andrew Keshner
Want your loved one in a nursing home to get a COVID-19 vaccine? Ask these questions first There are approximately 3 million people living in long-term care facilities, according to the CDCThere are approximately 3 million people living in long-term care facilities, according to the CDC.
2:18 a.m. Dec. 7, 2020 - By Quentin Fottrell
Joe Biden’s pandemic plan: Restore Obamacare, mandatory masks, paid sick leave and free COVID-19 tests The President-elect said: ‘Dealing with the coronavirus pandemic is one of the most important battles our administration will face’The President-elect said: ‘Dealing with the coronavirus pandemic is one of the most important battles our administration will face.’
10:12 a.m. Dec. 2, 2020 - By Quentin Fottrell
‘Cytokine Storm’ — the ‘intriguing’ similarity between COVID-19 and the 1918 influenza A hyperinflammatory immune response to the influenza of 1918 was seen as one reason healthy people were so hard hit. How big a role has it played in 2020?A hyperinflammatory immune response to the influenza of 1918 was seen as one reason healthy people were so hard hit. How big a role has it played in 2020?
3:01 a.m. Nov. 29, 2020 - By Andrew Keshner
Americans pay more for prescription drugs than anyone else. Can Amazon Pharmacy change that? What the e-commerce behemoth’s entry into the pharmacy business could mean for consumers’ health and wealthWhat the e-commerce behemoth’s entry into the pharmacy business could mean for consumers’ health and wealth
12:57 a.m. Nov. 26, 2020 - By Meera Jagannathan
The CDC says you shouldn’t travel for Thanksgiving — how to reduce risk of infection if you do ‘The safest way to celebrate Thanksgiving is to celebrate at home with the people you live with,’ the agency said ‘The safest way to celebrate Thanksgiving is to celebrate at home with the people you live with,’ the agency said.
10:55 a.m. Nov. 25, 2020 - By Ciara Linnane
Hospital workers called exhausted as U.S. records highest number of COVID deaths since May Parts of Europe are reporting declining cases and Sicily has asked Cuba to send doctors and nursesThe U.S. recorded the highest number of deaths from the coronavirus illness COVID-19 since May on Tuesday, and continues to average close to 200,000 new cases a day, with hospitals across the nation reporting exhausted health care workers and steadily filling intensive care units.
11:10 a.m. Nov. 24, 2020 - By Ciara Linnane
U.S. is ‘in the middle of the Fight of the Century,’ says former CDC head as cases rise in 45 states, hospitalizations set record U.S. has averaged 173,147 cases a day in the past week, and more than 85,000 COVID-19 patients are in a hospitalThe U.S. case tally from the coronavirus illness COVID-19 climbed above 12.84 million on Tuesday and hospitalizations again reached record levels, with 45 states reporting rising infections.
2:09 a.m. Nov. 23, 2020 - By Ciara Linnane
South Dakota emergency-room nurse says some patients insist COVID-19 isn’t real even as they’re dying from it ‘When they should be spending time FaceTime-ing their families, they’re just filled with anger and hatred. I just can’t believe those are their last words,’ says nurse Jodi DoeringA South Dakota nurse took to Twitter on Sunday to highlight a tragic feature of the coronavirus pandemic, patients who rail against health-care workers because they don’t believe that COVID-19 is real.
1:03 a.m. Nov. 17, 2020 - By Cecilia Clark
College students suspended for breaking COVID-19 rules—can you get a refund? Know your school’s COVID-19 policies and how they affect tuition money and financial aid if you don’t complyStudents returned this fall to rigid COVID-19 prevention rules. And noncompliance can be costly.
2:42 a.m. Nov. 9, 2020 - By Jaimy Lee
To defeat COVID-19, ‘we need a unified national strategy,’ says public health expert Dr. Howard Koh Koh served as assistant secretary of health during the H1N1 flu pandemic in 2009Dr. Howard Koh knows what it’s like to be a government official running a pandemic response.
9:08 a.m. Nov. 3, 2020 - By Bruce Horovitz
Life will never be the same for people over 60 — even with a COVID-19 vaccine These are the likely long-term impacts on gatherings, travel, eating, medicine, home life and even public restroomsMost will keep taking precautions. Here’s a preview of post-vaccine life for older Americans.
12:07 p.m. Oct. 30, 2020 - By Nicole Lyn Pesce
Watch: Georgia debate gets heated as Sen. David Perdue is labeled a ‘crook’ by rival Jon Ossoff Ossoff calls incumbent a coward as Perdue pulls out of third debate, which had been set for SundayThe third debate has been canceled after Perdue pulled out
3:27 a.m. Oct. 29, 2020 - By Ciara Linnane
Coronavirus update: Pandemic sets record case numbers across the U.S. as White House suggests the crisis is over U.S. has counted a record 500,000 new cases in the past week, and hospitals in isolated areas of the Midwest are rapidly fillingThe coronavirus pandemic continued to set records across the U.S. on Wednesday, even as the administration of President Donald Trump touted its first-term accomplishments in a news release that suggested it had ended the crisis that has cost more than 226,000 American lives and shows no signs of abating.
2:17 a.m. Oct. 28, 2020 - By Ciara Linnane
Coronavirus update: U.S. case tally tops 8.7 million and marks seven-day record, with more than 20 states seeing most new cases since start of the outbreak Dr. Birx says North Dakotans’ failure to wear face masks is ‘deeply unfortunate’ as the Dakotas suffer worst case numbers measured per capitaThe U.S. case tally for the coronavirus illness COVID-19 climbed above 8.7 million on Tuesday, with more than 20 states counting record numbers of new infections, as more business curfews were announced to combat the spread.
10:40 a.m. Oct. 26, 2020 - By Ciara Linnane
Coronavirus update: U.S. death toll tops 225,000 and Trump’s chief of staff says U.S. is ‘not going to control the pandemic’ In the past week, the U.S. has averaged 69,804 cases a day, up 32% from the average two weeks ago, a New York Times tracker showsThe U.S. death toll from the coronavirus illness COVID-19 rose above 225,000 on Monday, with more than 20 states reaching record levels of new infections, and President Donald Trump’s chief of staff said the U.S. is ‘not going to control the pandemic.’
5:25 a.m. Oct. 20, 2020 - By Quentin Fottrell
Trump calls Dr. Fauci a ‘disaster’ — Fauci tells Americans: ‘Stay away from the politics’ The president said, ‘Every time he goes on television there’s always a bomb, but there’s a bigger bomb if you fire him’The president said, ‘Every time he goes on television there’s always a bomb, but there’s a bigger bomb if you fire him.’
11:18 a.m. Oct. 19, 2020 - By Ciara Linnane
Coronavirus update: Global cases top 40 million; White House task force reported to be hive of infighting over new adviser White House Task Force beset by internal strife over adviser who is spreading misinformation, says Washington PostThe number of confirmed cases of the coronavirus illness COVID-19 worldwide climbed above 40 million on Monday, as new infections continued to rise in Europe and the U.S. and experts warned the pandemic could worsen during the cold winter months.
4:10 a.m. Oct. 19, 2020 - By Jaimy Lee
CVS to hire 15,000 workers as it pushes for pharmacy techs to be allowed to administer vaccinesShares of CVS Health Corp. gained 0.6% in premarket trading on Monday after the retail giant announced plans to hire 15,000 full-time and part-time workers in the fourth quarter as it prepares for rising cases of COVID-19 and flu season. Two-thirds of the jobs are for licensed pharmacy technicians, a group of professionals that CVS wants to be allowed to administer COVID-19 vaccines, if and when they become available. There are currently only six states - Idaho, Michigan, Nevada, Rhode Island, Utah, and Washington - that allow pharmacy technicians to administer vaccines, according to a CVS spokesperson. The company is also looking to fill jobs for pharmacists, nurses, physician assistants, and distribution center and customer-service workers. The Trump administration on Friday with CVS and Walgreens Boots Alliance Inc. for the drugstore chains to administer COVID-19 vaccines to residents of long-term care facilities in the future. Shares of CVS are down 19.8% for the year, while the S&P 500 is up 7.8%.
3:21 a.m. Oct. 18, 2020 - By Quentin Fottrell
Dr. Fauci: ‘This is an outbreak of historic proportions, the likes of which we’ve not seen in 102 years’ The veteran immunologist said, ‘I think we’re facing a whole lot of trouble’The veteran immunologist said, ‘I think we’re facing a whole lot of trouble.’
Browse topics:

Filter results by

Location

Us (252)

Asia Pacific (45)

Europe (42)

China (36)

Eu (32)

Latin America (9)

Link to MarketWatch's Slice.